JP2024510900A5 - - Google Patents
Info
- Publication number
- JP2024510900A5 JP2024510900A5 JP2023551754A JP2023551754A JP2024510900A5 JP 2024510900 A5 JP2024510900 A5 JP 2024510900A5 JP 2023551754 A JP2023551754 A JP 2023551754A JP 2023551754 A JP2023551754 A JP 2023551754A JP 2024510900 A5 JP2024510900 A5 JP 2024510900A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- acid sequence
- nucleotide sequence
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163153879P | 2021-02-25 | 2021-02-25 | |
| US63/153,879 | 2021-02-25 | ||
| US202163263231P | 2021-10-28 | 2021-10-28 | |
| US63/263,231 | 2021-10-28 | ||
| US202263309380P | 2022-02-11 | 2022-02-11 | |
| US63/309,380 | 2022-02-11 | ||
| PCT/US2022/017733 WO2022182890A1 (en) | 2021-02-25 | 2022-02-24 | Codon-optimized nucleotide sequences encoding an ap-1 transcription factor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510900A JP2024510900A (ja) | 2024-03-12 |
| JP2024510900A5 true JP2024510900A5 (https=) | 2025-03-19 |
Family
ID=80999862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023551754A Pending JP2024510900A (ja) | 2021-02-25 | 2022-02-24 | Ａｐ－１転写因子をコードするコドン最適化ヌクレオチド配列 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12270032B2 (https=) |
| EP (1) | EP4298230A1 (https=) |
| JP (1) | JP2024510900A (https=) |
| KR (1) | KR20230150834A (https=) |
| AU (1) | AU2022226655A1 (https=) |
| CA (1) | CA3174248A1 (https=) |
| WO (1) | WO2022182890A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021189008A1 (en) | 2020-03-20 | 2021-09-23 | Lyell Immunopharma, Inc. | Novel recombinant cell surface markers |
| US12144827B2 (en) | 2021-02-25 | 2024-11-19 | Lyell Immunopharma, Inc. | ROR1 targeting chimeric antigen receptor |
| EP4298230A1 (en) | 2021-02-25 | 2024-01-03 | Lyell Immunopharma, Inc. | Codon-optimized nucleotide sequences encoding an ap-1 transcription factor |
| WO2025089255A1 (ja) * | 2023-10-23 | 2025-05-01 | 慶應義塾 | 長期生存型ｔ細胞、医薬組成物、及び使用方法 |
| WO2025131119A1 (en) * | 2023-12-22 | 2025-06-26 | Everest Medicines (China) Co., Ltd. | Cancer vaccines and uses thereof |
| WO2025184170A1 (en) * | 2024-02-27 | 2025-09-04 | Overt Bio, Inc. | Methods and compositions for improving t cell function in an immunosuppressive environment |
| WO2025199252A1 (en) * | 2024-03-19 | 2025-09-25 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Inducible transcription factor expression for modulating immune cell function |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US20090226474A1 (en) | 2004-05-27 | 2009-09-10 | Weidanz Jon A | Antibodies as T cell receptor mimics, methods of production and uses thereof |
| CN101851668A (zh) | 2009-08-10 | 2010-10-06 | 芮屈生物技术（上海）有限公司 | 一种ap-1基因的原位杂交检测试剂盒及其检测方法和应用 |
| TR201904484T4 (tr) | 2009-11-03 | 2019-05-21 | Hope City | Transdüse T hücre seçimine yönelik kesik epiderimal büyüme faktörü reseptörü (EGFRt). |
| WO2013151665A2 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| CN108064176A (zh) * | 2015-04-22 | 2018-05-22 | 库瑞瓦格股份公司 | 用于治疗肿瘤疾病的含有rna的组合物 |
| GB201515351D0 (en) | 2015-08-28 | 2015-10-14 | Cancer Res Technology | Antibody |
| CN106636210B (zh) | 2016-10-09 | 2019-07-19 | 广州暨南大学医药生物技术研究开发中心 | 转录因子组合诱导成纤维细胞转分化为类睾丸间质细胞的方法 |
| GB201621889D0 (en) | 2016-12-21 | 2017-02-01 | Autolus Ltd | Cell |
| US11629340B2 (en) | 2017-03-03 | 2023-04-18 | Obsidian Therapeutics, Inc. | DHFR tunable protein regulation |
| JP7538601B2 (ja) | 2017-04-26 | 2024-08-22 | ユーリカ セラピューティックス， インコーポレイテッド | キメラ活性化受容体及びキメラ刺激受容体を発現する細胞並びにその使用 |
| EP3723774A4 (en) * | 2017-12-15 | 2021-09-08 | The Board of Trustees of the Leland Stanford Junior University | COMPOSITIONS AND METHODS OF INHIBITION OF T-CELL EXHAUSTATION |
| US20210299223A1 (en) | 2018-07-31 | 2021-09-30 | Washington University | Use of interleukin-7 and chimeric antigen receptor (car)-bearing immune effector cells for treating tumor |
| SG11202111865UA (en) | 2019-05-01 | 2021-11-29 | Pact Pharma Inc | Compositions and methods for the treatment of cancer using a tet2 engineered t cell therapy |
| WO2021142376A1 (en) * | 2020-01-08 | 2021-07-15 | Obsidian Therapeutics, Inc. | Compositions and methods for tunable regulation of transcription |
| EP4298230A1 (en) | 2021-02-25 | 2024-01-03 | Lyell Immunopharma, Inc. | Codon-optimized nucleotide sequences encoding an ap-1 transcription factor |
| US12144827B2 (en) | 2021-02-25 | 2024-11-19 | Lyell Immunopharma, Inc. | ROR1 targeting chimeric antigen receptor |
-
2022
- 2022-02-24 EP EP22714031.6A patent/EP4298230A1/en active Pending
- 2022-02-24 WO PCT/US2022/017733 patent/WO2022182890A1/en not_active Ceased
- 2022-02-24 AU AU2022226655A patent/AU2022226655A1/en not_active Abandoned
- 2022-02-24 KR KR1020237032290A patent/KR20230150834A/ko active Pending
- 2022-02-24 CA CA3174248A patent/CA3174248A1/en active Pending
- 2022-02-24 JP JP2023551754A patent/JP2024510900A/ja active Pending
- 2022-02-24 US US17/679,977 patent/US12270032B2/en active Active
-
2025
- 2025-03-05 US US19/071,604 patent/US20250297268A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024510900A5 (https=) | ||
| JP2024518011A5 (https=) | ||
| JP2022507830A5 (https=) | ||
| DK2836511T3 (en) | POLYPEPTIDE TO BE USED FOR ADOPTIVE CELL THERAPY | |
| JP2024507996A5 (https=) | ||
| JP2023518049A5 (https=) | ||
| FI3844267T3 (fi) | Menetelmät kimeeristä antigeenireseptoria ilmentävien solujen valmistamiseksi | |
| JP2017504601A5 (https=) | ||
| JP2021532742A5 (https=) | ||
| IL273201B1 (en) | Novel platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy | |
| US20190031759A1 (en) | Chimeric antigen receptors and methods of their use | |
| JP2019518424A5 (https=) | ||
| RU2018122106A (ru) | Буферы для стабилизации лентивирусных препаратов | |
| JP2022545167A5 (https=) | ||
| JP2019525956A5 (https=) | ||
| JP2022512913A5 (https=) | ||
| CN114656569A (zh) | 包含nkg2d结构域的多特异性嵌合受体和其使用方法 | |
| WO2021030153A2 (en) | Engineered t cell receptors and uses thereof | |
| JP2023548467A5 (https=) | ||
| CN110511912A (zh) | 免疫细胞的功能调节 | |
| JP2023548829A5 (https=) | ||
| JP2023549098A5 (https=) | ||
| IL312302A (en) | Methods for creating cells | |
| JP2023518293A (ja) | 新規の組換え細胞表面マーカー | |
| CN115427554A (zh) | 扩增t细胞治疗癌症和相关恶性肿瘤的方法 |